MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字H20244092

June 18, 2024

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

2.5ml:5mg(按C₁₃H₂₁NO₃计)

化学药品

June 18, 2024

Company Information

Applicant Company

山东省济南市高新区天泺路88号1号楼A座4楼402室

Manufacturing Company

山东省聊城市茌平区振兴街道华鲁街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath